BMED, established in 2017, has taken its place in the Turkish pharmaceutical industry with its products used in the treatment of rare diseases.

The target of BMED, which is in cooperation with the leading companies of the world, is to provide the treatment of rare diseases in many branches, especially Endocrinology, Organ Transplantation, Hematology, Oncology, Rheumatology, Infectious Diseases to patients in an easy and reliable way, within the framework of ethical and scientific values. 

    BMED Corporate Policies

    Our Ethical Business Rules;

  •  Our work within the framework of local laws regarding interaction with Healthcare Professionals

  • Depending on local laws related to anti-bribery and anti-corruption laws,

  • Subject to Local Labor Ethics Laws,

  • We carry out in line with our company SOPs.

You can write or call us for everything about BMED Pharmaceuticals.
Contact information